Key result
Tafazzin deficiency drives neuromuscular remodeling, muscle fiber atrophy, and motor unit loss in preclinical Barth syndrome.
Why the study?
Does deficient cardiolipin remodelling caused by Tafazzin mutation alter neuromuscular connectivity and muscle fibre composition in a Barth Syndrome model?
Does deficient cardiolipin remodelling caused by Tafazzin mutation alter neuromuscular connectivity and muscle fibre composition in a Barth Syndrome model?
Skeletal myopathy in Barth Syndrome may arise from cumulative structural neuromuscular adaptations and stress signalling rather than resting mitochondrial ATP insufficiency.
Neuromuscular remodeling may drive Barth myopathy beyond energetic failure; hypothesis-generating for targeted therapies pending human validation.
Whole-body deficiency of tafazzin enzymatic activity, as occurs in BTHS, is sufficient to result in widespread neuromuscular remodelling, including fibre size/type shifts, motor unit loss, NMJ dysregulation and stress pathway activation, without overt energetic failure at rest. These findings suggest that myopathy in BTHS arises not solely from mitochondrial ATP insufficiency but rather from cumulative structural and signalling adaptations.
No takes yet. Share an insight, caveat, or question.
Matias et al. (2026) studied Barth Syndrome. Tafazzin D75H point mutation (TazPM) vs. Wild-type littermates was evaluated. Deficiency of tafazzin enzymatic activity in a Barth syndrome mouse model resulted in widespread neuromuscular remodeling, including smaller muscle fibers and motor unit loss, without resting energetic failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: